Updated Date: Tue, 11 Jan 2022 00:00:00 EST

Updated Date: Tue, 11 Jan 2022 00:00:00 EST

A new study has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).

Researchers at Karolinska Institutet in Sweden have together with international collaborators completed a comprehensive international validation of artificial […]

Computer engineers and radiologists at Duke University have developed an artificial intelligence platform to analyze potentially cancerous lesions […]

Last Thursday, NHS England and NHS Improvement published the latest monthly performance figures and sixth week of winter […]

bmj;376/jan18_22/o81/FAF1faMadan R Bahl had a career spanning several decades, working in Kenya, Zambia, and England. As a consultant, […]

bmj;376/jan18_23/o94/FAF1faIn 1968, when Peter Campion was a medical student at Oxford, his first paper appeared in Nature. Over […]

Inside the Catalent FDA citation said to trigger Novo Nordisk’s Wegovy supply hiccup fkansteiner Tue, 01/18/2022 – 09:39

The wait is over: AbbVie’s Rinvoq chalks up FDA win with favorable atopic dermatitis label aliu Tue, 01/18/2022 […]